Fate Therapeutics Reports Second Quarter 2017 Financial Results
Aug 14, 2017 20:01 pm UTC| Business
First Subject Treated with FATE-NK100 in VOYAGE for Acute Myelogenous Leukemia FDA Clears Investigational New Drug Applications for FATE-NK100 in Recurrent Ovarian Cancer and in Advanced Solid Tumors with Monoclonal...
Reata Pharmaceuticals, Inc. Announces Second Quarter 2017 Financial and Operating Results
Aug 14, 2017 20:01 pm UTC| Business
IRVING, Texas, Aug. 14, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30,...
Ramaco Resources, Inc. Announces Second Quarter 2017 Results
Aug 14, 2017 20:01 pm UTC| Business
LEXINGTON, Ky., Aug. 14, 2017 -- Ramaco Resources, Inc. (NASDAQ:METC) (“Ramaco Resources”) today announced its results for the quarter ended June 30, 2017 highlighted by the receipt of its mining permit for its low...
Aug 14, 2017 20:01 pm UTC| Business
HINGHAM, Mass., Aug. 14, 2017 -- Microbot Medical Inc. (NASDAQ:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today reported financial...
Cumulus Reports Operating Results for Second Quarter 2017
Aug 14, 2017 20:00 pm UTC| Business
ATLANTA, Aug. 14, 2017 -- Cumulus Media Inc. (NASDAQ:CMLS) (the “Company,” “we,” “us,” or “our”) today announced operating results for the three and six months ended June 30, 2017. For the three months ended...
Famous Dave’s of America, Inc. Reports Results for Second Quarter Fiscal 2017
Aug 14, 2017 20:00 pm UTC| Business
MINNEAPOLIS, Aug. 14, 2017 -- Famous Dave's of America, Inc. (NASDAQ:DAVE) today reported financial results for the second quarter ending July 2, 2017. Highlights for the second quarter of 2017: Franchise-operated...
Intrusion Inc. Releases Financial Results for Second Quarter 2017
Aug 14, 2017 20:00 pm UTC| Business
RICHARDSON, Texas, Aug. 14, 2017 -- Intrusion Inc. (OTCQB:INTZ), (“Intrusion”) announced today financial results for the three and six months ended June 30, 2017. Intrusion’s net loss was $438 thousand in the second...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows